Medpace (MEDP)
(Real Time Quote from BATS)
$394.33 USD
-5.88 (-1.47%)
Updated Apr 30, 2024 11:59 AM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Medpace Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 282.81 | 245.37 | 181.85 | 145.38 | 100.44 |
Depreciation/Amortization & Depletion | 26.33 | 21.72 | 20.45 | 18.82 | 23.34 |
Net Change from Assets/Liabilities | 106.49 | 106.06 | 66.71 | 66.26 | 35.59 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 17.75 | 14.91 | -5.68 | 28.21 | 42.49 |
Net Cash From Operating Activities | 433.37 | 388.05 | 263.33 | 258.68 | 201.87 |
Property & Equipment | -36.65 | -36.88 | -28.27 | -31.34 | -17.91 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 2.02 | -1.86 | -3.09 | 0.13 | -1.23 |
Net Cash from Investing Activities | -34.63 | -38.74 | -31.36 | -31.21 | -19.14 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -132.64 | -825.78 | -44.45 | -82.28 | 6.52 |
Issuance (Repayment) of Debt | -50.00 | 50.00 | 0.00 | 0.00 | -80.44 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -182.64 | -775.78 | -44.45 | -82.28 | -73.92 |
Effect of Exchange Rate Changes | 1.08 | -6.57 | -3.97 | 0.67 | -0.17 |
Net Change In Cash & Equivalents | 217.18 | -433.04 | 183.54 | 145.85 | 108.64 |
Cash at Beginning of Period | 28.27 | 461.30 | 277.77 | 131.92 | 23.28 |
Cash at End of Period | 245.45 | 28.27 | 461.30 | 277.77 | 131.92 |
Diluted Net EPS | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 |
Fiscal Year End for Medpace Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 102.59 | 282.81 | 204.51 | 133.96 | 72.89 |
Depreciation/Amortization & Depletion | 6.99 | 26.33 | 19.36 | 12.48 | 5.96 |
Net Change from Assets/Liabilities | 38.18 | 106.49 | 33.67 | 0.76 | -6.45 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.91 | 17.75 | 19.44 | 15.40 | 7.68 |
Net Cash From Operating Activities | 152.68 | 433.37 | 276.98 | 162.59 | 80.08 |
Property & Equipment | -5.50 | -36.65 | -26.66 | -17.96 | -9.51 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 8.03 | 2.02 | 0.03 | -0.01 | 0.01 |
Net Cash from Investing Activities | 2.53 | -34.63 | -26.63 | -17.97 | -9.50 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.66 | -132.64 | -134.17 | -139.89 | -117.68 |
Issuance (Repayment) of Debt | 0.00 | -50.00 | -50.00 | 5.00 | 65.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.66 | -182.64 | -184.17 | -134.89 | -52.68 |
Effect of Exchange Rate Changes | -1.31 | 1.08 | 0.76 | 1.14 | 0.77 |
Net Change In Cash & Equivalents | 161.56 | 217.18 | 66.94 | 10.87 | 18.66 |
Cash at Beginning of Period | 245.45 | 28.27 | 28.27 | 28.27 | 28.27 |
Cash at End of Period | 407.01 | 245.45 | 95.21 | 39.14 | 46.92 |
Diluted Net EPS | 3.20 | 2.46 | 2.22 | 1.93 | 2.27 |